Physician
Family Medicine & Rehabilitation Center, PC
Family Medicine & Rehabilitation Center, PC was paid $2.03M by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoFAMILY MEDICINE & REHABILITATION CENTER, PC
GOLDSBORO, NC 27534
GOLDSBORO, NC 27534
33aNPI1457436917assigned 10/25/2006
33bProvider typePain Medicine (Physical Medicine & Rehabilitation) Physician
28Total paid$2.03M
24GClaims86,435
24DCodes billed37
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pain Medicine (Physical Medicine & Rehabilitation) Physician providers in North Carolina
Rank by total paid#1 of 12
Median peer was paid$57K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,261 | $413K | |
| 2019 | 10,262 | $348K | |
| 2020 | 5,934 | $202K | |
| 2021 | 11,526 | $316K | |
| 2022 | 14,558 | $318K | |
| 2023 | 17,137 | $231K | |
| 2024incomplete | 14,757 | $205K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 14,330 | 10,183 | $621K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 22% | 7,748 | 4,039 | $444K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 9,230 | 6,004 | $273K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 5.9% | 1,900 | 793 | $121K |
| Q3014 | Telehealth originating site facility fee | 5.6% | 9,206 | 4,911 | $115K |
| 99199 | Unlisted special service, procedure or report | 5.0% | 31,749 | 27,175 | $102K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 4.4% | 1,427 | 1,057 | $89K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 3.1% | 1,383 | 951 | $63K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.6% | 1,268 | 913 | $53K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 2.1% | 438 | 271 | $42K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.0% | 1,654 | 1,148 | $21K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.0% | 1,102 | 579 | $20K |
25 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 999 | $15K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,340 | $13K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 204 | $12K |
| 86328 | <1% | 274 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 71 | $4K |
| 99205 | Prolong outpt/office vis | <1% | 46 | $3K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 175 | $3K |
| 99401 | <1% | 184 | $3K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 55 | $2K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 132 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 13 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 85 | $1K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 281 | $635.06 |
| 99406 | <1% | 96 | $441.35 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 146 | $372.10 |
| 95923 | <1% | 24 | $359.32 | |
| 82962 | <1% | 369 | $351.59 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 235 | $261.90 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 85 | $237.51 |
| 95921 | <1% | 24 | $230.96 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 35 | $182.55 |
| 93000 | <1% | 19 | $114.39 | |
| 98925 | <1% | 31 | $18.27 | |
| 99000 | 0% | 63 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAHMED, MAQSOOD (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Andor Labs LLC | Morrisville, NC | $11.15M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.